Biomarin
  • Company
    • About Us
    • Our Origin Story
    • Leadership Team
    • Board of Directors
    • Responsibility
    • Giving
  • Patients
    • Patients
    • Patient Support
    • RARE Scholars
    • Expanded Access
  • Science & Medicine
    • Our Science
    • Medicines
    • Pipeline
    • Manufacturing
    • Clinical Trials
    • Publications
    • Medical Information
    • External Scientific Support
  • News
    • Newsroom
    • Stories
    • Press Releases
    • Company Statements
  • Careers
    • Careers at BioMarin
    • Fellowships
  • Investors
  • Locations
  • Contact
  • Locations
  • Contact
Search
  • Home

News

Read the latest updates about BioMarin and learn more about our science, our people and the communities we support.

Cristin Hubbard
  • People and Culture

Cristin Hubbard Reflects on a Career Spent Bringing Innovation to Patients – and Why Working at BioMarin Has Her More Energized Than Ever

August 7, 2026

Becky Curran
  • Community

Becky Jackson Curran Advocates for Accessibility and Understanding

July 14, 2026

Megan Bull
  • People and Culture
  • Science

Megan Bull’s Childhood Empathy Fuels a Career of Impact

July 23, 2026

Stories

All Stories
Cristin Hubbard
  • People and Culture

Cristin Hubbard Reflects on a Career Spent Bringing Innovation to Patients – and Why Working at BioMarin Has Her More Energized Than Ever

August 7, 2026

Megan Bull
  • People and Culture
  • Science

Megan Bull’s Childhood Empathy Fuels a Career of Impact

July 23, 2026

Becky Curran
  • Community

Becky Jackson Curran Advocates for Accessibility and Understanding

July 14, 2026

Londyn and Connor Episode 3
  • Community

Why Do I Pheel This Way? Episode 3: Finding Strength Through Sports While Living with Phenylketonuria

June 25, 2026

Devesh Radhakrishnan
  • Community
  • People and Culture
  • Science

From Unexpected Turns to Purposeful Impact

June 24, 2026

Why Do I Pheel This Way? Episode 2
  • Community

Why Do I Pheel This Way? Episode 2 Explores Social Life, Support and Self-Advocacy for Teens with Phenylketonuria  

June 11, 2026

Press Releases

All Press Releases

BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin’s Pipeline

August 18, 2026

BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston

August 10, 2026

BioMarin Reports Second Quarter 2026 Financial and Operating Results

August 6, 2026

BioMarin to Host Second Quarter 2026 Financial Results Conference Call and Webcast on Thursday, August 6, 2026, at 4:30pm ET

July 30, 2026

BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome

July 27, 2026

Company Statements

All Company Statements

Social

  • LinkedIn
  • X
  • Instagram
  • Facebook

You’re leaving the BioMarin website.

Links to sites outside of this website are provided as a resource to the viewer. BioMarin accepts no responsibility for the content of linked sites.

Leave this website Close

Enter your DIN number

Please locate the 8-digit DIN number found on your product package or educational materials and enter it in the form below to access important safety information.

Biomarin
Contact
  • Publication Data Request
  • Report an Adverse Event
  • Report a Product Complaint
  • Product Replacement Request
  • Submit a Medical Information Inquiry
Legal
  • Supply Chain Statement
  • Biomarin Data Privacy Center
  • Terms of Use
  • Cookie Settings
  • LinkedIn
  • X
  • Instagram
  • Facebook

© 2026 BioMarin. All rights reserved.